Acetate/acetyl-CoA metabolism associated with cancer fatty acid synthesis: Overview and application

Cancer Letters

Volumn 356, Issue 2, 2015, Pages 211-216

  Yoshii, Yukie ^a   Furukawa, Takako ^a   Saga, Tsuneo ^a   Fujibayashi, Yasuhisa ^a  

^a NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

Author keywords

Acetate; Acetyl CoA; Fatty acid; Metabolism; Positron emission tomography

Indexed keywords

ACETIC ACID; ACETIC ACID C 11; ACETYL COENZYME A; ACETYL COENZYME A SYNTHETASE; CITRIC ACID; FATTY ACID SYNTHASE; FATTY ACID SYNTHASE INHIBITOR; FLUOROACETIC ACID; FLUOROACETIC ACID F 18; UNCLASSIFIED DRUG; ACETATE-COA LIGASE (ADP-FORMING); ACETIC ACID DERIVATIVE; FATTY ACID; LONG CHAIN FATTY ACID COENZYME A LIGASE;

ACETIC ACID METABOLISM; ACETYL COENZYME A METABOLISM; CANCER DIAGNOSIS; CANCER METABOLISM; CITRIC ACID CYCLE; DISEASE ASSOCIATION; DRUG TARGETING; FATTY ACID SYNTHESIS; HUMAN; HYPOXIA; MALIGNANT NEOPLASTIC DISEASE; METABOLIC REGULATION; METABOLISM; NONHUMAN; PERSONALIZED MEDICINE; POSITRON EMISSION TOMOGRAPHY; PREDICTION; SHORT SURVEY; TREATMENT OUTCOME; UPREGULATION; BIOSYNTHESIS; CELL HYPOXIA; LIPOGENESIS; NEOPLASMS; PHYSIOLOGY; PROCEDURES;

ACETATES; ACETYL COENZYME A; CELL HYPOXIA; COENZYME A LIGASES; FATTY ACIDS; HUMANS; INDIVIDUALIZED MEDICINE; LIPOGENESIS; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; UP-REGULATION;

EID: 84920165655     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2014.02.019     Document Type: Review

References (66)

1. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
2. Dang C.V., Semenza G.L. Oncogenic alterations of metabolism. Trends Biochem. Sci. 1999, 24:68-72.
3. Weiss L., Hoffmann G.E., Schreiber R., Andres H., Fuchs E., Korber E., Kolb H.J. Fatty-acid biosynthesis in man, a pathway of minor importance. Purification, optimal assay conditions, and organ distribution of fatty-acid synthase. Biol. Chem. Hoppe-Seyler 1986, 367:905-912.
4. Migita T., Ruiz S., Fornari A., Fiorentino M., Priolo C., Zadra G., Inazuka F., Grisanzio C., Palescandolo E., Shin E., Fiore C., Xie W., Kung A.L., Febbo P.G., Subramanian A., Mucci L., Ma J., Signoretti S., Stampfer M., Hahn W.C., Finn S., Loda M. Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer. J. Natl. Cancer Inst. 2009, 101:519-532.
5. Carvalho M.A., Zecchin K.G., Seguin F., Bastos D.C., Agostini M., Rangel A.L., Veiga S.S., Raposo H.F., Oliveira H.C., Loda M., Coletta R.D., Graner E. Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model. Int. J. Cancer 2008, 123:2557-2565.
6. Kuhajda F.P. Fatty acid synthase and cancer: new application of an old pathway. Cancer Res. 2006, 66:5977-5980.
7. Rossi S., Graner E., Febbo P., Weinstein L., Bhattacharya N., Onody T., Bubley G., Balk S., Loda M. Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol. Cancer Res. 2003, 1:707-715.
8. Menendez J.A., Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat. Rev. Cancer 2007, 7:763-777.
9. De Schrijver E., Brusselmans K., Heyns W., Verhoeven G., Swinnen J.V. RNA interference-mediated silencing of the fatty acid synthase gene attenuates growth and induces morphological changes and apoptosis of LNCaP prostate cancer cells. Cancer Res. 2003, 63:3799-3804.
10. Kridel S.J., Axelrod F., Rozenkrantz N., Smith J.W. Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity. Cancer Res. 2004, 64:2070-2075.
11. Liu H., Liu J.Y., Wu X., Zhang J.T. Biochemistry, molecular biology, and pharmacology of fatty acid synthase, an emerging therapeutic target and diagnosis/prognosis marker. Int. J. Biochem. Mol. Biol. 2010, 1:69-89.
12. Yoshii Y., Furukawa T., Oyama N., Hasegawa Y., Kiyono Y., Nishii R., Waki A., Tsuji A.B., Sogawa C., Wakizaka H., Fukumura T., Yoshii H., Fujibayashi Y., Lewis J.S., Saga T. Fatty acid synthase is a key target in multiple essential tumor functions of prostate cancer: uptake of radiolabeled acetate as a predictor of the targeted therapy outcome. PLoS One 2013, 8:e64570.
13. Bauer D.E., Hatzivassiliou G., Zhao F., Andreadis C., Thompson C.B. ATP citrate lyase is an important component of cell growth and transformation. Oncogene 2005, 24:6314-6322.
14. Hatzivassiliou G., Zhao F., Bauer D.E., Andreadis C., Shaw A.N., Dhanak D., Hingorani S.R., Tuveson D.A., Thompson C.B. ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell 2005, 8:311-321.
15. Israel M., Schwartz L. The metabolic advantage of tumor cells. Mol. Cancer 2011, 10:70.
16. Yoshii Y., Waki A., Furukawa T., Kiyono Y., Mori T., Yoshii H., Kudo T., Okazawa H., Welch M.J., Fujibayashi Y. Tumor uptake of radiolabeled acetate reflects the expression of cytosolic acetyl-CoA synthetase: implications for the mechanism of acetate PET. Nucl. Med. Biol. 2009, 36:771-777.
17. 11C-acetate uptake and cell survival in hepatocellular carcinoma. J. Nucl. Med. 2009, 50:1222-1228.
18. Fujino T., Kondo J., Ishikawa M., Morikawa K., Yamamoto T.T. Acetyl-CoA synthetase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate. J. Biol. Chem. 2001, 276:11420-11426.
19. Howard B.V., Howard W.J., Bailey J.M. Acetyl coenzyme A synthetase and the regulation of lipid synthesis from acetate in cultured cells. J. Biol. Chem. 1974, 249:7912-7921.
20. Sone H., Shimano H., Sakakura Y., Inoue N., Amemiya-Kudo M., Yahagi N., Osawa M., Suzuki H., Yokoo T., Takahashi A., Iida K., Toyoshima H., Iwama A., Yamada N. Acetyl-coenzyme A synthetase is a lipogenic enzyme controlled by SREBP-1 and energy status. Am. J. Physiol. Endocrinol. Metab. 2002, 282:E222-230.
21. Luong A., Hannah V.C., Brown M.S., Goldstein J.L. Molecular characterization of human acetyl-CoA synthetase, an enzyme regulated by sterol regulatory element-binding proteins. J. Biol. Chem. 2000, 275:26458-26466.
22. Yoshimoto M., Waki A., Yonekura Y., Sadato N., Murata T., Omata N., Takahashi N., Welch M.J., Fujibayashi Y. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl. Med. Biol. 2001, 28:117-122.
23. 11C]-acetate metabolism in hepatocellular carcinoma. Mol. Imaging Biol. 2011, 13:140-151.
24. 11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer. J. Nucl. Med. 2008, 49:327-334.
25. Furuta E., Pai S.K., Zhan R., Bandyopadhyay S., Watabe M., Mo Y.Y., Hirota S., Hosobe S., Tsukada T., Miura K., Kamada S., Saito K., Iiizumi M., Liu W., Ericsson J., Watabe K. Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1. Cancer Res. 2008, 68:1003-1011.
26. Loffler M., Schneider F. Lipogenesis in Ehrlich ascites tumor cells under anaerobic culture conditions. J. Cancer Res. Clin. Oncol. 1979, 95:115-122.
27. Yoshii Y., Furukawa T., Yoshii H., Mori T., Kiyono Y., Waki A., Kobayashi M., Tsujikawa T., Kudo T., Okazawa H., Yonekura Y., Fujibayashi Y. Cytosolic acetyl-CoA synthetase affected tumor cell survival under hypoxia: the possible function in tumor acetyl-CoA/acetate metabolism. Cancer Sci. 2009, 100:821-827.
28. Karan D., David J.R., Capy P. Molecular evolution of the AMP-forming acetyl-CoA synthetase. Gene 2001, 265:95-101.
29. Starai V.J., Celic I., Cole R.N., Boeke J.D., Escalante-Semerena J.C. Sir2-dependent activation of acetyl-CoA synthetase by deacetylation of active lysine. Science 2002, 298:2390-2392.
30. Schwer B., Bunkenborg J., Verdin R.O., Andersen J.S., Verdin E. Reversible lysine acetylation controls the activity of the mitochondrial enzyme acetyl-CoA synthetase 2. Proc. Natl. Acad. Sci. USA 2006, 103:10224-10229.
31. Beinert H., Green D.E., Hele P., Hift H., Von Korff R.W., Ramakrishnan C.V. The acetate activating enzyme system of heart muscle. J. Biol. Chem. 1953, 203:35-45.
32. Jones M.E., Black S., Flynn R.M., Lipmann F. Acetyl coenzyme a synthesis through pyrophosphoryl split of adenosine triphosphate. Biochim. Biophys. Acta 1953, 12:141-149.
33. Barak R., Prasad K., Shainskaya A., Wolfe A.J., Eisenbach M. Acetylation of the chemotaxis response regulator CheY by acetyl-CoA synthetase purified from Escherichia coli. J. Mol. Biol. 2004, 342:383-401.
34. Hiatt A.J., Evans H.J. Influence of certain cations on activity of acetic thiokinase from spinach leaves. Plant Physiol. 1960, 35:673-677.
35. Frenkel E.P., Kitchens R.L. Purification and properties of acetyl coenzyme A synthetase from bakers' yeast. J. Biol. Chem. 1977, 252:504-507.
36. Duntze W., Neumann D., Gancedo J.M., Atzpodien W., Holzer H. Studies on the regulation and localization of the glyoxylate cycle enzymes in Saccharomyces cerevisiae. Eur. J. Biochem. 1969, 10:83-89.
37. Klein H.P., Jahnke L. Variations in the localization of acetyl-coenzyme A synthetase in aerobic yeast cells. J. Bacteriol. 1971, 106:596-602.
38. Klein H.P., Jahnke L. Effects of aeration on formation and localization of the acetyl coenzyme A synthetases of Saccharomyces cerevisiae. J. Bacteriol. 1979, 137:179-184.
39. Polakis E.S., Bartley W. Changes in the enzyme activities of Saccharomyces cerevisiae during aerobic growth on different carbon sources. Biochem. J. 1965, 97:284-297.
40. Rogers P.J., Stewart P.R. Respiratory development in Saccharomyces cerevisiae grown at controlled oxygen tension. J. Bacteriol. 1973, 115:88-97.
41. Takasaki K., Shoun H., Yamaguchi M., Takeo K., Nakamura A., Hoshino T., Takaya N. Fungal ammonia fermentation, a novel metabolic mechanism that couples the dissimilatory and assimilatory pathways of both nitrate and ethanol. Role of acetyl CoA synthetase in anaerobic ATP synthesis. J. Biol. Chem. 2004, 279:12414-12420.
42. Plathow C., Weber W.A. Tumor cell metabolism imaging. J. Nucl. Med. 2008, 49(Suppl. 2):43S-63S.
43. 11C-acetate PET imaging of prostate cancer. J. Nucl. Med. 2002, 43:181-186.
44. 11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse. J. Nucl. Med. 2003, 44:549-555.
45. Shreve P., Chiao P.C., Humes H.D., Schwaiger M., Gross M.D. Carbon-11-acetate PET imaging in renal disease. J. Nucl. Med. 1995, 36:1595-1601.
46. 11C-acetate PET imaging in hepatocellular carcinoma and other liver masses. J. Nucl. Med. 2003, 44:213-221.
47. 11C-acetate. Eur. J. Nucl. Med. Imaging 2006, 33:420-427.
48. 18F-FDG PET. Nucl. Med. Biol. 2008, 35:171-176.
49. Porenta G., Cherry S., Czernin J., Brunken R., Kuhle W., Hashimoto T., Schelbert H.R. Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging. Eur. J. Nucl. Med. 1999, 26:1465-1474.
50. Schelbert H.R. PET contributions to understanding normal and abnormal cardiac perfusion and metabolism. Ann. Biomed. Eng. 2000, 28:922-929.
51. Henes C.G., Bergmann S.R., Walsh M.N., Sobel B.E., Geltman E.M. Assessment of myocardial oxidative metabolic reserve with positron emission tomography and carbon-11 acetate. J. Nucl. Med. 1989, 30:1489-1499.
52. Choi Y., Huang S.C., Hawkins R.A., Hoh C.K., Krivokapich J., Buxton D.B., Armbrecht J.J., Sun K.T., Phelps M.E., Schelbert H.R. A refined method for quantification of myocardial oxygen consumption rate using mean transit time with carbon-11-acetate and dynamic PET. J. Nucl. Med. 1993, 34:2038-2043.
53. Hele P. The acetate activating enzyme of beef heart. J. Biol. Chem. 1954, 206:671-676.
54. Brown M., Marshall D.R., Sobel B.E., Bergmann S.R. Delineation of myocardial oxygen utilization with carbon-11-labeled acetate. Circulation 1987, 76:687-696.
55. 11C]acetate and dynamic positron emission tomography. Circulation 1989, 79:134-142.
56. Klein L.J., Visser F.C., Knaapen P., Peters J.H., Teule G.J., Visser C.A., Lammertsma A.A. Carbon-11 acetate as a tracer of myocardial oxygen consumption. Eur. J. Nucl. Med. 2001, 28:651-668.
57. Tamaki N., Magata Y., Takahashi N., Kawamoto M., Torizuka T., Yonekura Y., Tadamura E., Okuda K., Ono S., Nohara R., Kambara H., Konishi J. Oxidative metabolism in the myocardium in normal subjects during dobutamine infusion. Eur. J. Nucl. Med. 1993, 20:231-237.
58. Puig T., Turrado C., Benhamu B., Aguilar H., Relat J., Ortega-Gutierrez S., Casals G., Marrero P.F., Urruticoechea A., Haro D., Lopez-Rodriguez M.L., Colomer R. Novel inhibitors of fatty acid synthase with anticancer activity. Clin. Cancer Res. 2009, 15:7608-7615.
59. Lear J.L., Ackermann R.F. Evaluation of radiolabeled acetate and fluoroacetate as potential tracers of cerebral oxidative metabolism. Metab. Brain Dis. 1990, 5:45-56.
60. 18F]fluoroacetate - a simple and fast method using a commercial synthesizer. Nucl. Med. Biol. 2006, 33:153-158.
61. 11C-acetate. J. Nucl. Med. 2007, 48:420-428.
62. 18F-fluoroacetate using PET/CT. Eur. J. Nucl. Med. Mol. Imaging 2004, 31:797.
63. 18F-fluoroacetate. J. Nucl. Med. 2009, 50:982-990.
64. 13C hyperpolarized magnetic resonance using dynamic nuclear polarization. Chem. Soc. Rev. 2014, 43:1627-1659.
65. Jensen P.R., Peitersen T., Karlsson M., Zandt R., Gisselsson A., Hansson G., Meier S., Lerche M.H. Tissue-specific short chain fatty acid metabolism and slow metabolic recovery after ischemia from hyperpolarized NMR in vivo. J. Biol. Chem. 2009, 284:36077-36082.
66. Kurhanewicz J., Vigneron D.B., Brindle K., Chekmenev E.Y., Comment A., Cunningham C.H., Deberardinis R.J., Green G.G., Leach M.O., Rajan S.S., Rizi R.R., Ross B.D., Warren W.S., Malloy C.R. Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia 2011, 13:81-97.